Botanical species · safety record

Calystegia sepium

The EFSA Compendium of Botanicals holds 7 constituent measurements for Calystegia sepium. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Calystegia sepium (L.) R.Br.

7Constituent measurements
0Safety records
5Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Calystegines3
  • Calystegine b21
  • Calystegin a31
  • Cuscohygrine1
  • Lectins1

Plant parts

  • Roots and other underground parts4
  • Leaves1
  • Live plants1
  • Stem1
  • stalk1

Preparations

  • Solvent extraction1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
CalysteginesStem / stalk5.7 Gram/kilogramResolve DOI
CalysteginesLeaves2.3 Gram/kilogramResolve DOI
CalysteginesLive plantsResolve DOI
Calystegine b2Roots and other underground parts0.51 MicrogramGaschromatography (GC)Resolve DOI
Calystegin a3Roots and other underground parts1.08 MicrogramGaschromatography (GC)Resolve DOI
CuscohygrineRoots and other underground partsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
LectinsRoots and other underground partsResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. EVANS, WC., SOMANABANDHU, AO. CUSCOHYGRINE - CONSTITUENT OF ROOTS OF SOME BRITISH CONVOLVULACEAE. Phytochemistry, 1974, vol. 13, no. 2, p. 519-520. DOI
  2. Nakamura-Tsuruta, Sachiko., Uchiyama, Noboru., Peumans, Willy J., Van Damme, Els J. M., Totani, Kiichiro., Ito, Yukishige., Hirabayashi, Jun. Analysis of the sugar-binding specificity of mannose-binding-type Jacalin-related lectins by frontal affinity chromatography - an approach to functional classification . Febs journal, 2008, vol. 275, no. 6, p. 1227-1239. DOI
  3. Scholl, Y., Asano, N., Drager, B. Automated multiple development thin layer chromatography for calystegines and their biosynthetic precursors . Journal of chromatography a, 2001, vol. 928, no. 2, p. 217-224. DOI
  4. Scholl, Y., Hoke, D., Drager, B. Calystegines in Calystegia sepium derive from the tropane alkaloid pathway . Phytochemistry, 2001, vol. 58, no. 6, p. 883-889. DOI
  5. DRAGER, B. IDENTIFICATION AND QUANTIFICATION OF CALYSTEGINES, POLYHYDROXYL NORTROPANE ALKALOIDS . Phytochemical analysis, 1995, vol. 6, no. 1, p. 31-37. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue